secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001213900-21-037366
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pluristem Therapeutics appoints Prof. Varda Shalev and Doron Birger to Board
----------------------------------------------------------------------------

- Appointment effective July 15, 2021; each holds office until next annual shareholder meeting.
- Prof. Shalev is a professor of epidemiology at Tel Aviv University; previously CMO of Alike and led Maccabi Health Care's medical informatics.
- Doron Birger serves as chairman or director at multiple med-tech companies; holds BA and MA in economics from Hebrew University.
- Both will receive standard non-executive director fees as described in the 2020 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390021037366/0001213900-21-037366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390021037366/ea144418-8k_pluristem.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-037366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer